Discover Alaska's borealpox virus, formerly Alaskapox, now named for its ecosystem origins. Learn about this orthopoxvirus affecting humans and small mammals, with prevention insights.
A red-backed vole
(Adobe Stock 284886779 by David)
The Alaska Department of Health, in collaboration with the CDC and the World Health Organization, has officially renamed the Alaskapox virus to the borealpox virus as of April 2024. This update also includes changing the name of the corresponding disease from Alaskapox to borealpox.
The new name was chosen to reflect the virus's initial identification in the boreal ecosystem, which includes both humans and small mammal reservoirs. The name borealpox is more general and less specific than the previous name, which allows for the possibility of identifying the virus in small mammals and humans outside of Alaska's borders and into Canada and other areas.
Alaska Public Media (NPR) wrote that in a presentation at the Alaska Tribal Conference on Environmental Management held in Anchorage, Katherine Newell, PhD, MPH, a US CDC epidemiology field officer who works at the Alaska Department of Health, and spoke at a conference hosted by the Alaska Native Tribal Health Consortium, announcing the name change. “We are changing the name of Alaskapox virus to borealpox virus, which is what it will now be known as from now on.”
Borealpox virus, an orthopoxvirus, first emerged when a patient in Fairbanks, Alaska, was diagnosed with the disease in 2015. Orthopoxviruses are recognized to infect various mammals, including humans, often resulting in the development of skin lesions. Since its initial detection, 6 additional borealpox virus cases have been reported in Alaska, with 5 occurring among people residing in the Fairbanks North Star Borough and one case in the Kenai Peninsula Borough.
Although current data suggests that borealpox virus is mainly present among small mammals such as red-backed voles and shrews in the Fairbanks North Star Borough, it is possible that the virus is more prevalent in small mammal populations throughout Alaska. In addition, there may be cases of human infections that remain undiagnosed. The experts are also considering the potential role of domestic pets, such as cats and dogs, in transmitting the virus. The one death was from an immunocompromised individual who had been feeding a stray cat.
To date, no documented cases of human-to-human transmission of borealpox virus have been identified. However, given that certain orthopoxviruses can spread through direct contact with skin lesions, it is advised that individuals with skin lesions suspected to be caused by borealpox virus keep the affected area covered with a bandage to minimize potential transmission.
Among the small mammal species in Alaska, the northern red-backed vole stands out as one showing evidence of harboring the borealpox virus. Symptoms associated with borealpox infection typically include the presence of 1 or more skin lesions characterized by bumps or pustules. Additional symptoms may include swollen lymph nodes and joint and muscle pain. It is essential to note that immunocompromised individuals may face a heightened risk of experiencing more severe illness if infected with the borealpox virus.
According to the Infectious Diseases Society of America, the northern red-backed vole has a vast geographic range that extends across Alaska, parts of Canada, Russia, China, and Scandinavia. It won't be surprising if different borealpox viruses are found in patients and animal species in other regions of Alaska and other countries. Therefore, active epidemiologic surveillance and testing for susceptibility to antiviral drugs and vaccines available for mpox and smallpox in the US Strategic National Stockpile are required.
Vigilance in monitoring and understanding the virus's spread among both wildlife and human populations remains crucial for effective disease management and prevention strategies. The Alaska Department of Health continues to collaborate closely with health organizations to track the virus's progression and provide guidance to safeguard public health in the region.
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.